Business Description
HeartSciences Inc
NAICS : 423450
SIC : 5047
ISIN : US42254E3027
Total Employee Number:
12Description
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.88 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.46 | |||||
Debt-to-EBITDA | -0.51 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -17.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -71.5 | |||||
3-Year EBITDA Growth Rate | 45.9 | |||||
3-Year EPS without NRI Growth Rate | 47 | |||||
3-Year FCF Growth Rate | 43.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 35.95 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.81 | |||||
9-Day RSI | 57.22 | |||||
14-Day RSI | 58.24 | |||||
3-1 Month Momentum % | -9.62 | |||||
6-1 Month Momentum % | -42.68 | |||||
12-1 Month Momentum % | -67.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.19 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.8 | |||||
Days Inventory | 59604.5 | |||||
Days Sales Outstanding | 182.5 | |||||
Days Payable | 31663.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -139.9 | |||||
Shareholder Yield % | -8.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50 | |||||
Operating Margin % | -97450 | |||||
Net Margin % | -106062.5 | |||||
EBITDA Margin % | -95637.5 | |||||
FCF Margin % | -92425 | |||||
OCF Margin % | -91762.5 | |||||
ROE % | -354.52 | |||||
ROA % | -141.82 | |||||
ROIC % | -173.23 | |||||
3-Year ROIIC % | -126.92 | |||||
ROC (Joel Greenblatt) % | -969.71 | |||||
ROCE % | -282.03 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 392.86 | |||||
PB Ratio | 3.3 | |||||
Price-to-Tangible-Book | 16.18 | |||||
EV-to-EBIT | -1.22 | |||||
EV-to-EBITDA | -1.24 | |||||
EV-to-Revenue | 1189.88 | |||||
EV-to-Forward-Revenue | 23.72 | |||||
EV-to-FCF | -1.29 | |||||
Price-to-GF-Value | 1.06 | |||||
| Price-to-Net-Current-Asset-Value | 45.83 | |||||
Earnings Yield (Greenblatt) % | -81.97 | |||||
FCF Yield % | -81.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HSCS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HeartSciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.008 | ||
| EPS (TTM) ($) | -4.94 | ||
| Beta | -0.1281 | ||
| 3-Year Sharpe Ratio | -1.2 | ||
| 3-Year Sortino Ratio | -1.41 | ||
| Volatility % | 69.42 | ||
| 14-Day RSI | 58.24 | ||
| 14-Day ATR ($) | 0.309991 | ||
| 20-Day SMA ($) | 2.444 | ||
| 12-1 Month Momentum % | -67.19 | ||
| 52-Week Range ($) | 1.63 - 5.72 | ||
| Shares Outstanding (Mil) | 3.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HeartSciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HeartSciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2026-12-15 | In 156 days | ||
| First quarter earnings results for 2027 | 2026-09-11 | In 61 days | ||
| Annual report for 2026 | 2026-07-24 | In 12 days | ||
| Fourth quarter earnings results for 2026 | 2026-07-14 | In 2 days | ||
| General meeting for 2026 | 2026-04-30 10:00 | 1.98 (+1.02%) | ||
| Third quarter earnings results for 2026 | 2026-03-16 | 2.57 (-2.36%) | ||
| Second quarter earnings results for 2026 | 2025-12-15 | 2.55 (-6.93%) | ||
| First quarter earnings results for 2026 | 2025-09-11 | 3.31 (-2.36%) | ||
| Annual report for 2025 | 2025-07-24 | 3.83 (-3.04%) | ||
| Third quarter earnings results for 2025 | 2025-03-13 | 2.96 (-6.92%) |
Show
Entries
HeartSciences Inc Frequently Asked Questions
What is HeartSciences Inc(HSCS)'s stock price today?
The current price of HSCS is $2.75. The 52 week high of HSCS is $5.72 and 52 week low is $1.63.
When is next earnings date of HeartSciences Inc(HSCS)?
The next earnings date of HeartSciences Inc(HSCS) is 2026-07-14 Est..
Does HeartSciences Inc(HSCS) pay dividends? If so, how much?
HeartSciences Inc(HSCS) does not pay dividend.
Guru Commentaries on NAS:HSCS
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | 2026-06-23 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers